Cosentyx
Cosentyx ingredients
| Active ingredient | Strength |
|---|---|
| Secukinumab | 75 mg/.5mL, 150 mg/mL, 25 mg/mL, 300 mg/2mL |
What Cosentyx is used for
The FDA lists the approved uses on the official label (below). In the EU, secukinumab is approved as Cosentyx for:
Plaque psoriasis Cosentyx is indicated for the treatment of moderate to severe plaque psoriasis in adults and children from the age of 6 years old who are candidates for systemic therapy. Hidradenitis suppurativa (HS) Cosentyx is indicated for the treatment of active moderate to severe hidradenitis suppurativa (acne inversa) in adults with an inadequate response to conventional systemic HS therapy. Psoriatic arthritis Cosentyx, alone or in combination with methotrexate (MTX), is indicated for the treatment of active psoriatic arthritis in adult patients when the response to previous disease modifying anti rheumatic drug (DMARD) therapy has been inadequate. Axial spondyloarthritis (axSpA) Ankylosing spondylitis (AS, radiographic axial spondyloarthritis) Cosentyx is indicated for the treatment of active ankylosing spondylitis in adults who have responded inadequately to conventional therap…
EU wording from the European Medicines Agency; US approved uses can differ.
Key facts
- Brand
- Cosentyx
- Generic name
- Secukinumab
- Made by
- Novartis Pharmaceuticals Corporation
- Forms
- Injection, Injection, Solution, Concentrate
- Given
- Intravenous, Subcutaneous
- Drug class
- Interleukin-17A Antagonist
- FDA approval
- Biologic licence (BLA) BLA125504
- On the US market since
- 2015
Official information
- MedlinePlus drug information (search for Secukinumab)
In India
- Secukinumab: 1 brand in India
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Cosentyx?
Cosentyx (Secukinumab) is a specialist medicine made by Novartis Pharmaceuticals Corporation, approved by the US FDA.
What are the ingredients of Cosentyx?
Cosentyx contains Secukinumab (75 mg/.5mL, 150 mg/mL, 25 mg/mL, 300 mg/2mL).
Is Cosentyx approved in Europe?
The same active substance is approved in the EU as Cosentyx.
From the FDA National Drug Code directory (open.fda.gov, public domain) and the European Medicines Agency medicines list. Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA